Tenpoint Therapeutics, Ltd. kompaniyasidagi eng so‘nggi ish o‘rinlari

Tenpoint Therapeutics, Ltd. is a clinical-stage ophthalmology company developing medicines for presbyopia and other age-related eye conditions. Its research pipeline includes potential treatments for cataracts and geographic atrophy, with a focus on improving near vision through effects designed for useful duration and tolerability with daily use. The company works with eye care professionals as it advances its therapies through clinical development and regulatory review, including BRIMOCHOL™ PF, for which the FDA accepted a new drug application. Tenpoint Therapeutics is headquartered in Seattle.